Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,otherCurrentAssets,retainedEarnings,otherLiab,goodWill,treasuryStock,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,otherStockholderEquity,propertyPlantEquipment,totalCurrentAssets,longTermInvestments,shortTermInvestments,netReceivables,inventory,accountsPayable,deferredLongTermLiab,changeToLiabilities,WC,language,region,quoteType,triggerable,quoteSourceName,currency,priceHint,exchange,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchangeDataDelayedBy,shortName,marketState,market,regularMarketChangePercent,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,dividendDate,fiftyTwoWeekLow,fiftyTwoWeekHigh,trailingAnnualDividendRate,trailingPE,trailingAnnualDividendYield,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,forwardPE,epsTrailingTwelveMonths,epsForward,epsCurrentYear,priceEpsCurrentYear,bookValue,fiftyDayAverage,fiftyDayAverageChange,marketCap,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,esgPopulated,tradeable,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,Shares Short 4,Short Ratio 4,Short % of Float 4,Short % of Shares Outstanding 4,Shares Short (prior month ) 4,Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,CZMWF,1078153000.0,89440600,57404000,,79094000,17705000,54309000,84279000,230755000,89072000,89072000,,-1847000,,,,23921000,398456000,309384000,167701000,-9978000,,55173000,54309000,144045000.0,620137000.0,654447000.0,1545547000.0,114347000.0,2217699000.0,89441000.0,20211000.0,909534000.0,204559000.0,323349000.0,-73565000.0,104416000.0,8315000.0,347866000.0,88623000.0,-73565000.0,189302000.0,1451744000.0,4843000.0,9037000.0,1140103000.0,274078000.0,123336000.0,,0,1103878000.0,en-US,US,EQUITY,False,Delayed Quote,USD,2,PNK,220.8323,1629120616,0.0,220.832,220.8323,220.8323,10,0,CARL ZEISS MEDITEC AG,REGULAR,us_market,0.0,220.8323 - 220.8323,220.8323,0.0,0.0,0,0,finmb_2508428,Other OTC,Carl Zeiss Meditec AG,EUR,32,0,114.082306,1.0686867,106.75 - 220.8323,0.0,0.0,1496361600,106.75,220.8323,0.5,103.92108,0.0022641614,0.11416112,167.26144,53.57086,0.3202822,85.59392,2.125,2.58,2.77,79.722855,17.36,198.205,22.627304,19893854208,12.720755,15,America/New_York,EDT,-14400000,False,False,0.34,,,220.83,106.75,198.21,167.26,32,,89.44M,,36.38M,59.10%,22.57%,,,,,,0.61,0.32%,0.50,0.23%,,36.52%,"Jun 01, 2017","May 27, 2021",,,"Sep 29, 2020","Mar 30, 2021",11.46%,16.91%,6.83%,10.51%,1.39B,15.53,15.40%,745.52M,259.92M,159.09M,2.12,116.40%,17.35M,0.19,119.9M,7.67,4.17,17.36,290.68M,53.38M,Value,07745,Healthcare,3371,2,6,"Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, France, Spain, India, the United Kingdom, Turkey, North Africa, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases, as well as FORUM, an eye care data management system. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; products for surgical treatment of tumors or vascular diseases, such as aneurysms; and INTRABEAM, a intraoperative radiotherapy device. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.",Jena,49 3641 220 115,1,1609372800,1625097600,6,Germany,http://www.zeiss.de/meditec-ag/home.html,86400,4,Goschwitzer Strasse 51-52,49 3641 220 117,Medical Instruments & Supplies
t-1,CZMWF,1075881000.0,89440600,54200000,,66600000,17705000,46300000,82300000,207300000,73200000,73200000,-2400000.0,-1600000,,,,20300000,368900000,295700000,161600000,-6600000,,46300000,46300000,,,,1431717000.0,,,,,,,,,,,,,,,,,,,,,,0,,en-US,US,EQUITY,False,Delayed Quote,USD,2,PNK,220.8323,1629120616,0.0,220.832,220.8323,220.8323,10,0,CARL ZEISS MEDITEC AG,REGULAR,us_market,0.0,220.8323 - 220.8323,220.8323,0.0,0.0,0,0,finmb_2508428,Other OTC,Carl Zeiss Meditec AG,EUR,32,0,114.082306,1.0686867,106.75 - 220.8323,0.0,0.0,1496361600,106.75,220.8323,0.5,103.92108,0.0022641614,0.11416112,167.26144,53.57086,0.3202822,85.59392,2.125,2.58,2.77,79.722855,17.36,198.205,22.627304,19893854208,12.720755,15,America/New_York,EDT,-14400000,False,False,0.34,,,220.83,106.75,198.21,167.26,32,,89.44M,,36.38M,59.10%,22.57%,,,,,,0.61,0.32%,0.50,0.23%,,36.52%,"Jun 01, 2017","May 27, 2021",,,"Sep 29, 2020","Mar 30, 2021",11.46%,16.91%,6.83%,10.51%,1.39B,15.53,15.40%,745.52M,259.92M,159.09M,2.12,116.40%,17.35M,0.19,119.9M,7.67,4.17,17.36,290.68M,53.38M,Value,07745,Healthcare,3371,2,6,"Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, France, Spain, India, the United Kingdom, Turkey, North Africa, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases, as well as FORUM, an eye care data management system. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; products for surgical treatment of tumors or vascular diseases, such as aneurysms; and INTRABEAM, a intraoperative radiotherapy device. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.",Jena,49 3641 220 115,1,1609372800,1625097600,6,Germany,http://www.zeiss.de/meditec-ag/home.html,86400,4,Goschwitzer Strasse 51-52,49 3641 220 117,Medical Instruments & Supplies
t-2,CZMWF,1075881000.0,89440600,60204000,,76717000,18841000,53185000,84284000,210117000,65629000,65629000,-2400000.0,-18965000,,,,21896000,367552000,301923000,157435000,11088000,,54821000,53185000,22069000.0,620137000.0,562728000.0,1431717000.0,117213000.0,2013286000.0,89441000.0,15396000.0,808922000.0,212051000.0,333767000.0,-86783000.0,240834000.0,5202000.0,297584000.0,94572000.0,-86783000.0,119756000.0,1292752000.0,4108000.0,,979126000.0,286360000.0,91679000.0,115331000.0,0,995168000.0,en-US,US,EQUITY,False,Delayed Quote,USD,2,PNK,220.8323,1629120616,0.0,220.832,220.8323,220.8323,10,0,CARL ZEISS MEDITEC AG,REGULAR,us_market,0.0,220.8323 - 220.8323,220.8323,0.0,0.0,0,0,finmb_2508428,Other OTC,Carl Zeiss Meditec AG,EUR,32,0,114.082306,1.0686867,106.75 - 220.8323,0.0,0.0,1496361600,106.75,220.8323,0.5,103.92108,0.0022641614,0.11416112,167.26144,53.57086,0.3202822,85.59392,2.125,2.58,2.77,79.722855,17.36,198.205,22.627304,19893854208,12.720755,15,America/New_York,EDT,-14400000,False,False,0.34,,,220.83,106.75,198.21,167.26,32,,89.44M,,36.38M,59.10%,22.57%,,,,,,0.61,0.32%,0.50,0.23%,,36.52%,"Jun 01, 2017","May 27, 2021",,,"Sep 29, 2020","Mar 30, 2021",11.46%,16.91%,6.83%,10.51%,1.39B,15.53,15.40%,745.52M,259.92M,159.09M,2.12,116.40%,17.35M,0.19,119.9M,7.67,4.17,17.36,290.68M,53.38M,Value,07745,Healthcare,3371,2,6,"Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, France, Spain, India, the United Kingdom, Turkey, North Africa, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases, as well as FORUM, an eye care data management system. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; products for surgical treatment of tumors or vascular diseases, such as aneurysms; and INTRABEAM, a intraoperative radiotherapy device. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.",Jena,49 3641 220 115,1,1609372800,1625097600,6,Germany,http://www.zeiss.de/meditec-ag/home.html,86400,4,Goschwitzer Strasse 51-52,49 3641 220 117,Medical Instruments & Supplies
t-3,CZMWF,975647000.0,89440600,53110000,,5901000,18841000,5290000,75324000,137666000,9232000,9232000,-2400000.0,-2902000,,,,2341000,252974000,243742000,115308000,-3331000,,3560000,5290000,,,,1460087000.0,,,,,,,,,,,,,,,,,,,,,,0,,en-US,US,EQUITY,False,Delayed Quote,USD,2,PNK,220.8323,1629120616,0.0,220.832,220.8323,220.8323,10,0,CARL ZEISS MEDITEC AG,REGULAR,us_market,0.0,220.8323 - 220.8323,220.8323,0.0,0.0,0,0,finmb_2508428,Other OTC,Carl Zeiss Meditec AG,EUR,32,0,114.082306,1.0686867,106.75 - 220.8323,0.0,0.0,1496361600,106.75,220.8323,0.5,103.92108,0.0022641614,0.11416112,167.26144,53.57086,0.3202822,85.59392,2.125,2.58,2.77,79.722855,17.36,198.205,22.627304,19893854208,12.720755,15,America/New_York,EDT,-14400000,False,False,0.34,,,220.83,106.75,198.21,167.26,32,,89.44M,,36.38M,59.10%,22.57%,,,,,,0.61,0.32%,0.50,0.23%,,36.52%,"Jun 01, 2017","May 27, 2021",,,"Sep 29, 2020","Mar 30, 2021",11.46%,16.91%,6.83%,10.51%,1.39B,15.53,15.40%,745.52M,259.92M,159.09M,2.12,116.40%,17.35M,0.19,119.9M,7.67,4.17,17.36,290.68M,53.38M,Value,07745,Healthcare,3371,2,6,"Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, France, Spain, India, the United Kingdom, Turkey, North Africa, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery. This segment also offers optical coherence tomography devices, perimeters, fundus cameras, slit lamps, and therapeutic and refractive lasers for the diagnosis and treatment of various eye diseases, such as refraction, glaucoma, and other retinal diseases, as well as FORUM, an eye care data management system. The Microsurgery segment provides surgical microscopes and visualization solutions for neuro, spinal, dental, and plastic and reconstructive surgeries, as well as for ear, nose, and throat surgery; products for surgical treatment of tumors or vascular diseases, such as aneurysms; and INTRABEAM, a intraoperative radiotherapy device. Carl Zeiss Meditec AG serves ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.",Jena,49 3641 220 115,1,1609372800,1625097600,6,Germany,http://www.zeiss.de/meditec-ag/home.html,86400,4,Goschwitzer Strasse 51-52,49 3641 220 117,Medical Instruments & Supplies
